May 11, 2023
Shionogi achieved record highs on all levels of its earnings scorecard for FY2022, bolstered by a strong contribution from the government purchase of its COVID-19 pill Xocova (ensitrelvir) and sales of the antibiotic cefiderocol in the US and Europe. In...read more